Company intelligence / Profile preview

Bio-Techne Corporation

Minneapolis, Minnesota, United Statesbio-techne.com ↗

Ownership: Public · TECH
Employees: ~3100
Development stage: Commercial

Overview

Bio-Techne is a commercial-stage company providing high-quality reagents, analytical instruments, and precision diagnostics for research, diagnostic, and bioprocessing markets.

Therapeutic areas: CardiovascularMetabolic DisordersImmunologyOncologyNeurologyInfectious Diseases
Modalities: ReagentsAntibodiesProteinsCell Culture ReagentsCytokinesBioactive PeptidesSmall Molecules
Industry: Molecular Diagnostics

Partnerships

Oxford Nanopore Technologies

Financials

Market cap: $11.3B
Total revenue: $321.2M
Enterprise value: $11.3B

Beyond the preview

Go deeper on Bio-Techne Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Techne Corporation.

Explore the full profile